The utility of health states after stroke - A systematic review of the literature

被引:188
作者
Post, PN
Stiggelbout, AM
Wakker, PP
机构
[1] Leiden Univ, Med Ctr K6R, Dept Med Decis Making, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Vasc Surg, NL-2300 RC Leiden, Netherlands
关键词
cost-benefit analysis; decision analysis; outcome; quality of life;
D O I
10.1161/01.STR.32.6.1425
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background-To perform decision analyses that include stroke as one of the possible health states, the utilities of stroke states must be determined. We reviewed the literature to obtain estimates of the utility of stroke and explored the impact of the study population and the elicitation method. Summary of Review-We searched various databases for articles reporting empirical assessment of utilities. Mean utilities of major stroke (Rankin Scale 4 to 5) and minor stroke (Rankin Scale 2 to 3) were calculated, stratified by study population and elicitation method. Additionally, the modified Rankin Scale was mapped onto the EuroQol classification system, Utilities were obtained from 23 articles. Patients at risk for stroke assigned utilities of 0.26 and 0.55 to major and minor stroke, respectively. Stroke survivors assigned higher utilities to both major (0.41) and minor stroke (0.72). The EuroQol completed by stroke survivors revealed a utility of 0.32 and 0.71 for major and minor stroke, respectively. Utilities elicited by the Standard Gamble were generally higher, while those obtained by the Visual Analogue Scale were lower than the Time Trade Off values. Remaining variation between utilities may be caused by differences in definitions of the health states. The mapped EuroQol indicated a utility of 0.64 for minor stroke and a value just below zero for major stroke. Conclusions-For minor stroke, a utility between 0.50 and 0.70 seems to be reasonable for both decision analyses and cost-effectiveness studies. The utility of major stroke may range between 0 and 0.30 and may possibly be negative.
引用
收藏
页码:1425 / 1429
页数:5
相关论文
共 37 条
[1]  
Adar R, 1994, Cardiovasc Surg, V2, P582
[2]   INTEROBSERVER AGREEMENT FOR THE ASSESSMENT OF HANDICAP IN STROKE PATIENTS [J].
BAMFORD, JM ;
SANDERCOCK, PAG ;
WARLOW, CP ;
SLATTERY, J .
STROKE, 1989, 20 (06) :828-828
[3]   Depression and other determinants of values placed on current health state by stroke patients Evidence from the VA Acute Stroke (VASt) study [J].
Bosworth, HB ;
Horner, RD ;
Edwards, LJ ;
Matchar, DB .
STROKE, 2000, 31 (11) :2603-2609
[4]   Modeling valuations for EuroQol health states [J].
Dolan, P .
MEDICAL CARE, 1997, 35 (11) :1095-1108
[5]   Are the modified "simple questions" a valid and reliable measure of health related quality of life after stroke? [J].
Dorman, P ;
Dennis, M ;
Sandercock, P .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 69 (04) :487-493
[6]   Is the EuroQol a valid measure of health-related quality of life after stroke? [J].
Dorman, PJ ;
Waddell, F ;
Slattery, J ;
Dennis, M ;
Sandercock, P .
STROKE, 1997, 28 (10) :1876-1882
[7]   Defining post-stroke recovery: implications for design and interpretation of drug trials [J].
Duncan, PW ;
Lai, SM ;
Keighley, J .
NEUROPHARMACOLOGY, 2000, 39 (05) :835-841
[8]   MULTIATTRIBUTE HEALTH-STATUS CLASSIFICATION SYSTEMS - HEALTH UTILITIES INDEX [J].
FEENY, D ;
FURLONG, W ;
BOYLE, M ;
TORRANCE, GW .
PHARMACOECONOMICS, 1995, 7 (06) :490-502
[9]   THE BEAVER DAM HEALTH OUTCOMES STUDY - INITIAL CATALOG OF HEALTH-STATE QUALITY FACTORS [J].
FRYBACK, DG ;
DASBACH, EJ ;
KLEIN, R ;
KLEIN, BEK ;
DORN, N ;
PETERSON, K ;
MARTIN, PA .
MEDICAL DECISION MAKING, 1993, 13 (02) :89-102
[10]   COST-EFFECTIVENESS OF WARFARIN AND ASPIRIN FOR PROPHYLAXIS OF STROKE IN PATIENTS WITH NONVALVULAR ATRIAL-FIBRILLATION [J].
GAGE, BF ;
CARDINALLI, AB ;
ALBERS, GW ;
OWENS, DK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (23) :1839-1845